Watch: Utility of AI and ChatGPT in Rheumatology Dr. Kathryn Dao interviews Dr. Richard Stern at the 2023 ACR Convergence meeting in San Diego, CA. #ACR23 https://t.co/SH0TGAdvm8 https://t.co/RHu8bH9YOG

• Utility of AI and ChatGPT in Rheumatology | RheumNow

TM86 #ACR23 @RheumNow Auricular chondritis, arthritis, axonopathy, high inflamm. Initial Dx: RP Exam: lymphadenopathy, erythema nodosum, TJC 36, SJC 4 (knees/ankles), decr sensation, asymm reflex, macular rash, nerve thicken Skin bx: septal panniculitis wo vasc Dx: leprosy https://t.co/P5QJArRDaA

#Cardiovascular imaging will help to detect #cardiac abnormalities earlier@in #rheumatic #diseases. #ACR23 ⁦@RheumNow⁩ ⁦@ACRheum⁩ 14T118 https://t.co/QKCpLWtkUv

🚩Adjunct therapy to treat vasculopathy of MDA5-DM ⭐️Botox heals digital ulcerations and improves Raynaud's (slide 1) Dr. Katherine Shaw injects Botox for healing recalcitrant ulcerated Gottron's papules (example patient failed nifedipine, sildenafil, pentoxyfylline & while on… https://t.co/4XCvRrzeTL https://t.co/yxUCzS30W1

What do we know about IL1 drugs in #OA only a small few stidies prior to CANTOS . COLCHCINE didnt seem to work LoDoCO2 post hoc analysis may work? @RheumNow #ACR23 https://t.co/h4oVRppI5S

Gene signature predicts RA trajectory during pregnancy: Blood RNAseq *before* pregnancy 🚺 improve during preg: Strong Neutrophil signature 🚺 experience dis worsening: Strong B cell signature Needs replication but could have major implications! @RheumNow #ACR23 ABST2481 https://t.co/gOHwEvOOM6

#ACR23 Abstr# 2487 How to reduce PBO response in #SLE trials? Try adding low dose GC as co-primary endpoint. Interim analysis of Phase 2 RCT: SRI-4 + sustained GC dose to ≤5mg/d or ≤BL from Wk16 to 28 was met more in Ianalumab (BAFF-R-i) vs PBO (44% vs 9%) @RheumNow https://t.co/JEnMWKilR6

TM85 #ACR23 @RheumNow IPF s/p lung transplant p/w diffuse bone pain Exam: no synovitis, +crackles. Labs: ALP 203 CT chest: stable mycetoma Xray: periosteal reaction Dx: vericonazole periosititis Positive Mucorales PCR, fluoride level 19 (ref <4) Bone pain improved stopping voric https://t.co/Gt8mOAssvh

Anti-fibrotics in RA-ILD Retro analysis of 74 pts AEs frequent 55% and discontinuation in 46% (more than in initial RCTs) No diff between AF FCV trajectory mildly improved ABST2479 @RheumNow @Juge_P_A @PhilippeDieude #ACR23 https://t.co/GqsHxkIFgD

Rashes in Rheumatology at #ACR23 Which disease entity are these palms pathognomonic for? @RheumNow https://t.co/NmT1LTzWmm

Therapeutic Ladder for Discoid Lupus: 1. Strict🌞protection, smoking avoidance 2. Antimalarials 3. Topicals/intralesional corticosteroids, topical CNI 4. Oral steroids, retinoids, MTX, MMF 5. Thalidomide, lenalidomide 6. IVIG, JAKi, Belimumab... BUT also Anifrolumab!… https://t.co/xSw0s12Uvk https://t.co/stIJ944d9A

#ACR23 Abstr# 2485 Belimumab therapy in RCT was associated with increased risk of psychiatric events inc suicidality vs PBO. When compared with standard immunosuppressant, real-world data using emulated trial design showed no increased risk @RheumNow https://t.co/Vqhc5yRsSA

A new innovative way of teaching MS ultrasound to students using teledidactic teaching with portable ultrasound devices resulted in a significant increase in knowledge comparable to the conventional course, Schäfer SV, Abst#2079 #ACR23 @RheumNow https://t.co/re0gErx5ke https://t.co/yPbS9Rj0az

Late breaking at #ACR23: extension of this study for dazodalibep (anti-CD40L) for Sjogren’s symptoms Another six months with a crossover - & sustained symptomatic benefit after cessation. Fascinating, addresses a desperate clinical need, bring on the phase 3! ABSTL10 @RheumNow https://t.co/zUfnGEZefj https://t.co/S3lLwhwl85

Complements & HCQ? (Prof Petri et al) Significant ⬆️ in C3 (p=0.022) & C4 (p=0.003) levels with HCQ whole blood levels >50 ng/mL Increasing blood levels of HCQ significantly assocd w/⬆️prob of achieving normal C4 Improving C3,C4; addtl benefit of HCQ? #ACR23 ABST2327 @RheumNow https://t.co/5ucpXq9ngb